Table: Wakamoto Pharm -6-MTH parent results
Nov 2 (Reuters)-
Wakamoto Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2016 Sep 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 5.49 5.50 11.20
(-0.1 pct) (+4.1 pct) (+0.1 pct)
Operating loss 59 mln 74 mln 60 mln
(+531.8 pct) (-27.9 pct)
Recurring loss 51 mln 103 mln 40 mln
(+272.0 pct) (-68.0 pct)
Net loss 33 mln 61 mln 2 mln
(+441.3 pct) (-90.2 pct)
EPS loss 0.97 yen 1.77 yen 0.06 yen
Ann Div 3.00 yen
-Q2 div NIL NIL
-Q4 div 3.00 yen
NOTE - Wakamoto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T
((Tokyo Headline News Desk +813 6441 1812))